Clinical Research Life Science Nurses Regulation 
XTalks
OCTOBER 18, 2022
A clinical research organization (CRO) is a company that delivers outsourced services to plan, manage and execute clinical trials for biotechnology, pharmaceutical, and medical device companies. Read on to learn why life science and clinical research professionals are choosing a career with Medpace.
XTalks
AUGUST 9, 2024
Pharmaceutical, life sciences and healthcare organizations have long had the desire to make their research programs more accessible and patient-centric. One of the key elements to the successful execution of a decentralized clinical trial (DCT) is providing patients access to in-home specimen collections and assessments.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
OCTOBER 19, 2022
Following the news that the number of clinical trial recruiting sites in Ukraine has dropped by half since the Russian invasion, DDW’s Diana Spencer examines clinical trial data from analytics company Phesi and speaks to Dr Olena Karpenko , Clinical Research Director at Medical Center Ok!Clinic+ Dr Olena Karpenko.
XTalks
DECEMBER 22, 2022
NORD, along with its more than 330 member patient organizations, is committed to the identification, treatment and cure of rare disorders through education, advocacy, research and patient services. Since only about 5 percent of rare diseases have FDA-approved treatments, it is vital that we increase the pace of rare disease clinical research.
XTalks
JANUARY 19, 2022
The way in which clinical trials are conducted is entering a new dimension as clinical trial operations are becoming more adaptable. Richard Lee, MD, Senior Medical Director of the Medical Department at the global contract research organization (CRO) Medpace. What are Decentralized and Hybrid Clinical Trials?
XTalks
AUGUST 30, 2022
Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. In a recent webinar, Dr. Vornov described the history and current progress in targeted CNS therapeutic delivery.
XTalks
NOVEMBER 19, 2021
Even if a robust cardiac biomarker is identified, it can run into regulatory hurdles, which is why close relationships between sponsors and regulators is critically important in order to reduce time to qualification, making it important to work hand in hand, Dr. Januzzi says. A Functional Future State.
Expert insights. Personalized for you.
111 
Let's personalize your content